Acino ? Delivering Health
Acino ? Delivering Health Acino ? Delivering Health
In-house technologies Transdermal systems Location Miesbach, Germany Fentanyl & buprenorphine on the market, new formulations with USPs in development Rivastigmine EU submitted 2011, US submission targeted 2012 Development and production of a contraceptive patch for Bayer Healthcare Pharmaceuticals Additional customer projects under negotiation 10
In-house technologies Bio-degradable drug implants Location Miesbach, Germany Goserelin approved in several B2C markets, launch in Europe targeted 2013 Leuprorelin launch targeted for 2013 Customer projects are being evaluated Oral dispersibles Location Liesberg , Switzerland (and Miesbach, Germany) Technology for tablets (ODTs), films (ODFs) and pellets in stickpacks Project candidates under evaluation 11
- Page 1 and 2: Acino - Delivering Health Annual Re
- Page 3 and 4: 2011 operating performance EUR mill
- Page 5 and 6: Balance sheet EUR million 31.12.201
- Page 7 and 8: R&D and development pipeline Zurich
- Page 9: In-house technologies Complex, soli
- Page 13 and 14: From 2013 onwards 2-3 projects per
- Page 15 and 16: “Old” Acino: highly dependent o
- Page 17 and 18: 3-pillar business model of Acino Ac
- Page 19 and 20: The acquisition includes: The marke
- Page 21 and 22: Acquired business perfectly fits Ac
- Page 23 and 24: The “new” Acino: broad customer
- Page 25 and 26: Geographic break-down of revenue Ma
- Page 27 and 28: Our past and future strengths Expan
- Page 29 and 30: Key Facts: Acino TODAY Fourth large
- Page 31: Acino - Delivering Health Thank you
In-house technologies<br />
Transdermal systems<br />
Location Miesbach, Germany<br />
Fentanyl & buprenorphine on the market, new formulations with USPs in<br />
development<br />
Rivastigmine EU submitted 2011, US submission targeted 2012<br />
Development and production of a contraceptive patch for Bayer <strong>Health</strong>care<br />
Pharmaceuticals<br />
Additional customer projects under negotiation<br />
10
Change language